A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
Electroporation is an effective approach to deliver genes of interests into cells. By applying this approach in vivo on the neurons of adult mouse dorsal root ganglion (DRG), we describe a model to study axon regeneration in vivo.
Electroporation is an essential non-viral gene transfection approach to introduce DNA plasmids or small RNA molecules into cells. A sensory neuron in the dorsal root ganglion (DRGs) extends a single axon with two branches. One branch goes to the peripheral nerve (peripheral branch), and the other branch enters the spinal cord through the dorsal root (central branch). After the neural injury, the peripheral branch regenerates robustly whereas the central branch does not regenerate. Due to the high regenerative capacity, sensory axon regeneration has been widely used as a model system to study mammalian axon regeneration in both the peripheral nervous system (PNS) and the central nervous system (CNS). Here, we describe a previously established approach protocol to manipulate gene expression in mature sensory neurons in vivo via electroporation. Based on transfection with plasmids or small RNA oligos (siRNAs or microRNAs), the approach allows for both loss- and gain-of-function experiments to study the roles of genes-of-interests or microRNAs in regulation of axon regeneration in vivo. In addition, the manipulation of gene expression in vivo can be controlled both spatially and temporally within a relatively short time course. This model system provides a unique tool to investigate the molecular mechanisms by which mammalian axon regeneration is regulated in vivo.
Injuries in the nervous system caused by neural trauma or various neurodegenerative diseases usually result in defects in motor, sensory and cognitive functions. Recently, much effort has been devoted to regenerative potency re-establishment in adult neurons to restore the physiological functionsof injured neurons1,2,3. Sensory neurons in the DRG are a cluster of nerve cells that convey different sensory stimuli, such as pain, temperature, touch, or body posture, to the brain. Each of these neurons is pseudo-unipolar and contains a single axon that bifurcates with one branch extending toward the periphery and the other branch heading toward the spinal cord4. The adult sensory neurons in DRGs are among a few mature mammalian neurons known to regenerate their axons actively after injury. Hence, injuries of sensory axons have been extensively employed as a crucial model to study the mechanisms of axonal regeneration in vivo.
In vivo gene transfection techniques, which are usually less time-consuming to set up and more flexible than using transgenic animals, have been playing essential roles in studying the functions of genes and signaling pathways in the nervous system. The main techniques can be categorized into two approaches: instrument-based and virus-based5. Viral-based in vivo gene delivery in adult neurons can provide precise spatiotemporal manipulation of gene expression6. However, labor-intensive processes are involved in viral-based methods, such as the production and purification of viral particles containing the desired gene. In addition, many viral vectors could activate the immune system of the host, which may interfere with the data acquisition, data analysis and possibly mislead the interpretation of experimental results. Electroporation, a typical instrument-based transfection approach, uses an electrical pulse to increase the permeability of cell and nuclear membranes transiently, which favors the influx of gene vectors or small RNA oligos from space outside of the cells7. In vitro electroporation is widely recognized as a transient but highly efficient strategy for manipulating targeted gene expression in many cell types. Although in vivo electroporation only leads to transient gene expression with low transfecting efficiency compared to viral vectors, it has various advantages over viral approaches. For instance, it can be applied to almost all tissues and cells7,8,9. In addition, either plasmids encoding genes-of-interest or small RNA oligos (e.g., siRNAs, microRNAs) against certain transcripts can be injected into the target tissue directly and then electrically pulsed, which make the procedure less labor- and time- consuming. Moreover, transfecting multiple plasmids and RNA oligos simultaneously with single electroporation is possible.
We have established an in vivo electroporation approach to manipulate gene expression in adult mouse sensory neurons and successfully applied and validated such approach in numerous pioneer studies1,2,3,8,10. Here, we present a detailed protocol to facilitate the usage of this approach for future studies of mammalian axon regeneration.
All animal experiments were performed in accordance with the animal protocol approved by the Johns Hopkins Institutional Animal Care and Use Committee.
1. Materials and Reagents
2. Experimental Procedures
To quantify the cytotoxicity of the current protocol and to validate that transfection rate of in vivo DRG electroporation is high enough, we injected and electroporated fluorescently-tagged microRNA or siRNA into L4 and L5 DRGs. The detached DRGs were processed through cryo-sectioning and immunohistochemistry (Figure 1A-B). When estimating the cell survival rate after injection and electroporation, the intact DRGs from L4 and L5 wer...
Several surgical steps require particular attention. The L4 and L5 DRGs (location of somas), which dominate the sciatic nerve, need to be correctly identified and injected with gene constructs. Otherwise, the GFP-labeling will be absent in sciatic nerve axons. The iliac crests can be viewed as useful anatomical landmarks to pinpoint L4 and L5 DRGs. In most mice, the facet joint between L5 and L6 vertebrae is proximate to iliac crests12. Alternatively, L3 DRG can be chosen instead of L5, especially...
The authors have nothing to disclose.
The study was funded (awarded to F-Q.Z.) by NIH (R01NS064288, R01NS085176, R01GM111514, R01EY027347), the Craig H. Neilsen Foundation and the BrightFocus Foundation.
Name | Company | Catalog Number | Comments |
ECM 830 Square wave electroporation system | BTX Harvard Apparatus | 45-0052 | For in vivo electroporation |
Tweezertrodes electrodes | BTX Harvard Apparatus | 45-0524 | For in vivo electroporation, 1 mm flat |
Picospritzer III | Parker Instrumentation | 1096 | Intracellular Microinjection Dispense Systems |
Glass Capillary Puller | NARISHIGE | PC-10 | |
Borosilicate Glass Capillaries | World Precision Instruments, Inc. | 1902328 | |
Stereo Dissection Microscope | Leica | M80 | |
Microsurgery Rongeur | F.S.T | 16221-14 | |
Microsurgery Forceps | FST by DUMONT, Switzerland | 11255-20 | Only for sciatic nerve crush |
Glass Capillary | World Precision Instruments, Inc. | TW100-4 | 10 cm, standard wall |
Tape | Fisherbrand | 15-901-30 | For fixing the mouse on the corkboard |
2, 2, 2-Tribromoethanol (Avertin) | Sigma-Aldrich | T48402 | Avertin stock solution |
2-methyl-2-butanol | Sigma-Aldrich | 152463 | Avertin stock solution |
siRNA Fluorescent Universal Negative Control #1 | Sigma-Aldrich | SIC003 | Non-target siRNA with fluorescence |
microRNA Mimic Transfection Control with Dy547 | Dharmacon | CP-004500-01-05 | Non-target microRNA with fluorescence |
Plasmids preparation kit | Invitrogen Purelink | K210016 | GFP-coding plasmid preparation |
Fast Green Dye | Millipore-Sigma | F7252 | For better visualization of the DRG outline during injection |
Ketamine | Putney, Inc | NDC 26637-731-51 | Anesthesia induction |
Xylazine | AnaSed | NDC 59399-110-20 | Anesthesia induction |
Acetaminophen | McNeil Consumer Healthcare | NDC 50580-449-36 | Post-surgical pain relief |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved